Millennials are individuals who were born between the early-1980s and mid-1990s and are sandwiched between the Generations X (born mid-1960s to early-1980s) and Z (born mid-1990s to mid-to-late-2000s). I have heard many "senior" colleagues engaged in discussions about our younger "millennial" colleagues (a.k.a. Generation Y), particularly in relation to their entrance into the eyecare workforce and perceptions of "commitment" to their work or the profession.
One thing about which I like to remind colleagues is that millennials are generally thought to relish collaboration in their work endeavors and value the team-oriented approach to healthcare. Understanding this can be key to helping this generation find true satisfaction, and therefore "commitment," to their daily work in practice.
Jason J. Nichols, OD, MPH, PhD
B+L Announces U.S. Launch of Lumify
Bausch + Lomb (B+L) launched Lumify (brimonidine tartrate ophthalmic solution 0.025%), an over-the-counter (OTC) eye drop developed with low-dose brimonidine tartrate for the treatment of eye redness. Lumify is an alpha-2 (α2)-adrenergic receptor (AR) agonist with a unique method of action that selectively constricts venules while maintaining the availability of oxygen to surrounding tissue. The brimonidine tartrate ophthalmic solution 0.025% product was licensed by Eye Therapies, Inc. to Bausch & Lomb Incorporated or its affiliates.
Lumify is available for purchase at major retailers nationwide, including Walgreens, CVS, Rite Aid, Walmart, Target, and Amazon. The bottles, available in 2.5mL and 7.5mL sizes, have suggested retail prices of $14.99 and $25.99, respectively.
Valeant to Become Bausch Health Companies Inc.
Valeant Pharmaceuticals International, Inc. announced that it will change its name to Bausch Health Companies Inc., effective in July 2018. As part of the name change, the company will roll out a new corporate brand identity in July 2018, which will include new imagery and a new web site, and will trade under a new symbol, BHC. Until that time, the company will continue to trade on the New York Stock Exchange and Toronto Stock Exchange under its present symbol, VRX.
Takeda to Buy Shire for $62 Billion
Takeda Pharmaceutical agreed to buy Shire for 45.3 billion pounds ($62 billion). According to Takeda, the proposed acquisition of Shire will create a global R&D-driven biopharmaceutical leader headquartered in Japan. The two companies had been in deal negotiations for several weeks.
Under the terms of the acquisition, each Shire shareholder will be entitled to receive $30.33 in cash for each Shire share and either 0.839 new Takeda shares or 1.678 Takeda American Depositary Shares (ADSs). The transaction has been approved by both companies’ boards of directors and is expected to close in the first half of 2019, according to the announcement. Upon the closing of the transaction, Takeda shareholders will own approximately 50% of the combined group, according to the announcement.
Authorities Crack Down on Illegal Contact Lens Sales in Texas
Thirty-seven contact lens store owners and wholesale distribution companies have been ordered to stop selling unlawful and potentially dangerous contact lenses in Texas. According to the Texas Attorney General’s Office, the businesses have made refunds available to consumers and will pay more than $140,000 in civil penalties and attorneys’ fees to the state of Texas.
The Texas Attorney General’s office began its investigation in March 2016 after undercover sweeps by the San Antonio Police Department turned up more than two dozen stores selling contact lenses without requiring consumers to provide a prescription, which violated the Texas Deceptive Trade Practices Act and the Texas Optometry Act.
Ten companies – located primarily in San Antonio, Houston, and Dallas – marketed the lenses to novelty shops, corner stores, and gas stations, even though retailers could not legally sell them without a prescription.
1-800 Contacts to End Test of Brick-and-Mortar Stores
After testing Lumen Optical, a brick-and-mortal retail format, 1-800 Contacts has decided to close the remaining three stores in the Chicago area by the end of May. The company had opened the first Lumen Optical location in late 2016 and operated as many as four of the eyecare practices as of spring 2017. The Lumen Optical stores were about 3,000 to 3,500 square feet and featured new in-store looks.
Gelflex Secures Additional Supply Agreement with Vision Source
Australian contact lens company Gelflex has secured a deal to provide disposable contact lenses exclusively to Vision Source, a network of independent optometry practices. The deal, which is still pending U.S. Food and Drug Administration clearance of Gelflex’s lenses, is in addition to the company’s existing agreement to supply custom lenses to the more than 3,300 practices within the Vision Source network.
University of Pikeville Names Dean for Kentucky College of Optometry
University of Pikeville President Burton J. Webb announced the appointment of Michael Bacigalupi, OD, MS, as dean of the University of Pikeville-Kentucky College of Optometry (KYCO) effective July 1, 2018.
Dr. Bacigalupi has 13 years of experience in optometric education and previously served as the assistant dean for Student Affairs and Admissions at Nova Southeastern University (NSU)-College of Optometry in Ft. Lauderdale, Fla., where he was also assistant professor of optometry. During his tenure, he worked to enhance the college’s curriculum, establish partnerships within the institution, and form articulation agreements in the United States and China.
Early in his optometric career, Dr. Bacigalupi was in private practice in rural Texas, where he was the only eyecare provider in a medically underserved area. He served on the Texas Optometric Association Board of Directors in multiple capacities.
He is a fellow of the American Academy of Optometry and clinical examiner for the National Board of Examiners in Optometry. He also serves on the Association of Schools and Colleges of Optometry’s Student Affairs Committee, Culture Task Force, and Committee for Applicant Development, and he has fulfilled several roles in the American Optometric Association.
Call for Abstracts for Academy 2018 San Antonio Scientific Program
The Scientific Program Committee of the American Academy of Optometry invites the submission of abstracts for Academy 2018 San Antonio, which will be held Nov. 7 through Nov. 10. The Academy’s Scientific Program offers scientists, educators, and clinicians the opportunity to exchange the latest information in optometry and vision science in two formats: research paper presentations and scientific posters. Submissions will be accepted until May 31.
First authors (excluding students and residents) of accepted papers/posters are also eligible to register for Academy 2018 San Antonio at reduced rates. To read more about the submission guidelines or to submit an abstract, visit http://bit.ly/2HHgIic.
Al Vaske Joins Advanced Vision Technologies
Advanced Vision Technologies (AVT) and Al Vaske, founder of Lens Dynamic, Inc., announced a joint venture to provide a range of specialty contact lenses for irregular corneas. The AVT Team has launched a signature line of GP options, "Prime Lens Design," which includes small and large corneal and scleral lens modalities.
Mr. Vaske is known for bringing the Rose K and Dyna Intra-Limbal designs to the United States and saw the need for fitting sets to aid the doctor in fitting irregular corneas. He brings 40 years of experience in manufacturing, marketing, consulting, and lens options to AVT.
Call for Continuing Education Course Proposals for the 2019 Global Specialty Lens Symposium
The GSLS Education Planning Committee invites you to submit one-hour continuing education courses for consideration for the GSLS 2019, which will take place in Las Vegas from Jan. 24 to 27, 2019. The submission window will close at 5:00 p.m. ET on June 1, 2018.
The committee seeks the submission of new and innovative courses on all aspects of contact lenses (such as materials, designs, lens care) in addition to related topics such as corneal and ocular surface disease, diagnosis and treatment approaches, and practice management. Click here to submit your abstract.
Does your ability to use contact lens care starter kits influence your prescribing patterns associated with contact lens care solutions
This image shows persistence of a pupillary hyperplastic membrane, which is usually sporadic, occurring as a result of an alteration of the pupillary development during embryonic life. This patient was a 3-year-old girl who had microphthalmos, microcornea, and hypermetropia of +12.00D.
In infants, persistence of iris membrane is a more frequent feature than might be expected, especially in eyes with a dark iris. It may occur in a mild form, with a few nonpigmented filamentous branches in front of the pupil, which do not disturb sight at all and do not represent a clinically significant finding. Or, it may appear in a more severe form, with many pigmented shoots or even with a thicker membrane covering the entire pupil field.
We thank Dr. Lorè for this image and welcome photo submissions from our other readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
CARE SOLUTION CORNER
Andrew D. Pucker, OD, PhD
Insurance’s Influence on Vision Health
While it is great that many patients have both vision and medical insurance, practitioners often need to educate them about the differences between the two types of insurance. Although the two types have distinct differences, such as contact lens materials being more likely to be covered by vision insurance and eye diseases being more likely to be covered by medical insurance, does having vision insurance provide additional health benefits over having medical insurance alone?
A survey conducted by Li et al on subjects between the ages of 40- and 65-years-old suggests that vision insurance may have significant visual health benefits.1 Specifically, the authors found in their cohort of 27,152 subjects that 86% of their sample had medical insurance while only 59% of their sample had vision insurance.1 This study further discovered that those who had vision insurance were more likely to have had an eye exam in the past year and to report good vision compared to subjects who did not have vision insurance.1 Likewise, Li et al determined that having had an eye exam in the past year was associated with higher odds of reporting good vision, and their overall data suggests that having vision insurance is a more important factor for maintaining good eye health compared to having medical insurance alone.1
The American Optometric Association suggests that at-risk patients, such as contact lens wearers, should have annual eye exams to help prevent ocular disease.2 Because vision insurance promotes healthcare utilization and better overall vision health, it may be wise for you to also educate your patients about these points while educating them about their healthcare benefits.
Near the end of every consultation call, the local laboratory asks "…and what material would you like to use?" Honestly, the answers are probably nearly always the same. Practitioners share the fact that their favorite material has been working splendidly for their patients over the last couple of years. And, truth be told, there are fantastic materials for custom soft, GP, and scleral lenses. Material manufacturing partners continue to innovate polymer chemistry to bring about materials that are more wettable, more breathable, and better for patients.
Like most people, however, providers get stuck in the same old, same old rut. Every now and then, they may ask: "Is there anything new that I should be trying?" The consultants will then share what experience they are having with some new materials, what the advantages are, and why they might suggest it for patients. Typically, consultants aren’t trying to "sell" these products; they want practitioners to be happy, they want patients to be happy, and they want everyone to be successful.
So, the next time you’re ordering a lens for a patient, stop and ask your consultant "What is new that I should be trying?" You never know how it might change things for you and your patients.
Light Disturbance with Multifocal Contact Lens and Monovision for Presbyopia
Dysphotopsia affects a significant number of patients, particularly after visual correction with multifocal optical designs. The purpose of this study was to evaluate light distortion (LD) in two modalities of contact lens (CL) wear: multifocal (MF) and monofocal (MV).
This was a randomized, double-masked, crossover study involving 20 presbyopic patients. Patients were randomized first into either MF or MV for 15 days of use with a one-week washout period between each lens type. The LD was evaluated with the Light Distortion Analyzer (LDA, University of Minho) under monocular and binocular conditions. The light distortion index (LDI, %), among other parameters, was analyzed. Subjective quality of vision was assessed with the Quality of Vision (QoV) Questionnaire.
The LD showed an increase in all parameters in both CL modalities being significant for MV in the non-dominant eye (p < 0.030, for all LD parameters). For the MF, there was also a significant increase in LDI (p = 0.016) and in Best Fit Circle radius (BFCrad; p = 0.022) in the nondominant eye. After 15 days of MF lens wear, there was a significant decrease in all LD parameters (p < 0.002) in the dominant eye. Binocularly, a significant improvement from one to 15 days was observed for LDI (p = 0.009) and BFCrad (p = 0.0013) with MF. The QoV questionnaire showed no significant changes with either CL.
The study authors concluded that adaptation to light disturbances induced by MF CLs is more effective compared to MV. Practitioners will have greater success if they prepare their patients for the adaptation required as their vision will get better, and they will have less of an issue with light disturbance.
Fernandes P, Amorim-de-Sousa A, Queirós A, Escandón-Garcia S, McAlinden C, González-Méijome JM. Light disturbance with multifocal contact lens and monovision for presbyopia. Cont Lens Anterior Eye. 2018 May 22. [Epub ahead of print]